Infollion is a curated B2B expert network built on a take-rate model: it buys expert time and sells access to consulting firms, private equity funds and corporates. The core economics are simple. A wider, better-mapped panel lowers the cost of finding the right expert; a larger client base raises utilisation of that panel. Infollion says its panel is almost 1.55 lakh experts, most with 20-25 years of experience. H1 FY27 operating revenue was ₹59 crore, up almost 15% year on year and more than 20% sequentially; total revenue was about ₹60 crore. Gross margin was about 41%, EBITDA ₹7.7 crore and PAT ₹6.7 crore. The call compares EBITDA and PAT with the previous half, not year on year: EBITDA rose 27% and PAT 24% from the previous half. The company is profitable and cash-generative, but the margin is well below its own historical level and the earnings base is small.
The first operating issue is volume. H1 FY27 calls were almost 10,500, similar to last year. Revenue growth came from a higher ticket size, which management attributes to 5-7% inflationary increases plus a conscious premium pricing stance. That is a good outcome for revenue per call, but it leaves growth dependent on price and mix. Management said India had not shown a consistent trend and explicitly declined an H2 FY27 revenue outlook. Its only clear forward guidance is qualitative: the international share of revenue is likely to increase, and India might be better than H2 FY26 but is unquantified. My inference is that H2 FY27 revenue growth will depend more on pricing and international mix than on an India volume recovery. That is inference, not management guidance.
The second issue is margin. Gross margin was about 41% in H1 FY27. Management said it was comfortable with that level, would never say never to recovery, but gave no recovery guidance and said aggressive pricing could continue while it pursues market share and premium clients. It also said core India servicing cost as a percentage of revenue is likely to decline even as consolidated costs rise, because anything involving the US or AI is expensive. That is the operating-leverage mechanism: the mature India business can become more efficient, but the group may not show margin expansion while new initiatives carry costs. The bull case is not that group margins rise immediately. It is that the India core can fund the build while US, HUKSA and AI work move from cost centres to revenue contributors.
The third issue is international. US and MENA are growing faster than India, and EU is at the level MENA was a year earlier. But non-India client revenue remains in single digits. Management's eventual target is for international to be larger than the entire current business, with no deadline. That is an aspiration, not guidance. It also cautioned that a marketplace business can look almost flat in its early years while supply is seeded; a low base does not guarantee high growth. The concrete old milestone was roughly $1 million, or ₹8-10 crore, of US revenue before full-time US hiring. Q2 FY27 did not update it. The direction is right; the scale and timing remain unproven.
The fourth issue is HUKSA. Revenue almost doubled in H1 FY27 versus H1 FY26 and repeat rates were above 60%, but the base was almost ₹1 crore. Management is trying to shift HUKSA toward managed training services, which would make revenue stickier than one-off courses. It still says the business is discovering its fit, sees volatility, and has given no scale or breakeven target. HUKSA is therefore a credible option, not yet an earnings engine. Third Eye is earlier still: it targets expert work for enterprise AI agents, output evaluation and observability, but management says there is no material revenue or value yet and experiments will run over the next couple of years.
Capital allocation is conservative but scattered. Infollion paid about ₹60 lakh in H1 FY27 for a 19% stake in Thermium, with total consideration about ₹1.2 crore and roughly ₹30 lakh a quarter thereafter; the transcript also says 'next 2 months,' so the pacing is ambiguous. Thermium is in engineering services, including heat-pump installation, planning and design. Management calls it materially small and a standalone financial investment, while also using it to study an engineering-services marketplace. Most of the cash pile is earmarked for international expansion unless AI offers compelling ROI. This is not a balance-sheet risk at the current scale, but minority stakes and small experiments can absorb management attention without moving consolidated earnings.
Management delivery is only partly testable here. The supplied bundle contains one call, so I cannot independently verify the older promise chronology in existing research. In the current call management delivered a clear H1 financial picture, reported HUKSA near-doubling and repeated the mainboard qualification target. It also withheld a numeric H2 outlook, gave no margin recovery guide and did not provide international revenue numbers. That argues for treating new targets as operating milestones rather than forecasts.
The investment case therefore rests on whether Infollion can make core India cost efficiency fund the international and HUKSA build while price-led revenue growth holds and call volume eventually recovers. The evidence for operating leverage is management's statement that core India servicing cost as a percentage of revenue can decline. The evidence against is that H1 gross margin is about 41%, management gives no recovery guidance, and consolidated costs are rising for US and AI initiatives. The call gives no evidence yet that group margins are expanding.
Falsifiers are straightforward. If India call volume stays flat and ticket-size increases fade, revenue growth slows. If gross margin falls below 40% without a volume recovery, the pricing strategy is not working. If HUKSA growth stalls or repeat rates fall, the L&D option is worth less. If non-India client revenue stays in single digits through FY27, the international build is not converting. If cash goes into unrelated minority stakes or AI experiments without measurable returns, capital allocation is diluting focus. Conversely, a disclosed US revenue number near the old $1 million threshold, HUKSA sustaining growth with repeat contracts, or a mainboard move would validate parts of the operating-leverage thesis. No price target is implied.
companyname: Infollion Research Services Limited ticker: INFOLLION sector: B2B Human Cloud / Expert Network Infollion Research Services Limited is a marketplace that connects clients with subject matter experts on an on-demand basis. The company has operated for almost 15 years and built a panel of over 100,000 experts, most with 20 to 25 years of professional experience. The Managing Director described the model directly in the April 2025 concall: "We operate as a marketplace where we connec...
Read the full report →Management did not give a numeric revenue or margin guide. It said the international share of revenue is likely to increase, India might be better than H2 FY26 but was unquantified, and core India servicing cost as a percentage of revenue is likely to decline even as consolidated costs rise.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Infollion Research Services Ltd. and 4,900+ companies.
5-day free pass. No card required.